Ilika plc (AIM:IKA)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 66.06M -3.0% |
| Revenue (ttm) | 664.50K -61.8% |
| Net Income | -7.34M |
| EPS | -0.04 |
| Shares Out | 180.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 200,364 |
| Average Volume | 423,028 |
| Open | 37.80 |
| Previous Close | 36.50 |
| Day's Range | 36.00 - 38.00 |
| 52-Week Range | 24.00 - 51.00 |
| Beta | 2.12 |
| RSI | 62.55 |
| Earnings Date | May 8, 2026 |
About Ilika
Ilika plc engages in designing, production, and development of solid state batteries in the United Kingdom, Asia, Europe, and North America. The company offers solid state batteries for transportation under the Goliath name for electric vehicles and cordless consumer electronics. It also provides solid state batteries for healthcare under the Stereax name for neurostimulation, cardiac sensing, smart orthopaedics, smart orthodontics, smart contact lenses, and industrial IoT sensors. Ilika plc was founded in 2004 and is headquartered in Romsey, t... [Read more]
Financial Performance
In fiscal year 2025, Ilika's revenue was 1.05 million, a decrease of -49.64% compared to the previous year's 2.09 million. Losses were -5.90 million, 22.6% more than in 2024.
Financial StatementsNews
SMALL CAP IDEA: Ilika has cracked problems that have beaten BYD, Toyota and Samsung
Ilika, the business in question, also appears to have resolved many of the limiting issues that have thwarted the world's biggest carmakers and battery manufacturers.
Ilika Earnings Call Transcript: H1 2026
Stereax achieved first commercial deliveries and began generating revenue, while Goliath shipped 10Ah prototypes and opened licensing discussions. Turnover declined to £0.6M due to grant timing, but cash remains strong. Key 2026 milestones include Stereax integration and Goliath customer feedback.
Ilika Earnings Call Transcript: H2 2025
Solid-state battery developer reported FY revenue of GBP 1.1 million, down year-on-year due to grant timing, but expects Stereax production and revenue in 2025 and strong Goliath prototype validation. Cash reserves exceed GBP 11 million after a successful fundraise.
Ilika Transcript: Investor Update
Solid-state battery developer advances Stereax and Goliath product lines, with Stereax entering commercial production via Cirtec and Goliath achieving key prototype milestones. A GBP 3.5 million capital raise will support commercialization, with strong industry partnerships and a robust patent portfolio.
Ilika Earnings Call Transcript: H1 2025
Stereax production is set to begin in 2025 with initial revenues expected mid-year, while Goliath batteries advance through key technical milestones and licensing discussions. Cash burn is well managed, and grant funding continues to support scale-up, but revenue growth depends on successful commercialization and customer adoption.
Ilika Earnings Call Transcript: H2 2024
Asset-light licensing model drives growth in solid-state battery tech for medical and EV markets, with revenue up 200% year-over-year and cost reductions extending cash runway. Stereax commercialization set for 2025, while Goliath advances toward licensing and royalty revenue.
Ilika Earnings Call Transcript: H1 2022
OTC Markets Group Welcomes Ilika PLC. to OTCQX
NEW YORK, Sept. 10, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Ilika PLC.